Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) for Preventing Pertussis: Evidence of Rapidly Waning Immunity and Difference in Effectiveness by Tdap BrandKOEPKE, Ruth; EICKHOFF, Jens C; AYELE, Roman A et al.The Journal of infectious diseases. 2014, Vol 210, Num 6, pp 942-953, issn 0022-1899, 12 p.Article

Interferon as an in vitro modifier of immune responses induced by combined vaccine (DTP) in miceDIMITROV, N. V; MEYER, C; MITCHELL, J et al.Journal of immunopharmacology. 1983, Vol 5, Num 4, pp 291-310, issn 0163-0571Article

Les vaccins hexavalentsREINERT, Philippe.MTP. Médecine thérapeutique pédiatrie. 2001, Vol 4, Num MAI, issn 1286-5494, 35 p., HS1Serial Issue

Les associations vaccinalesMOREL, G; LANEL, V. B.NPN médecine. 1990, Num 169, pp 561-565, issn 0248-9635, 4 p.Article

Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem™) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugateTAMM, Eda; VERONESE, Alessandra; CONTORNI, Mario et al.Vaccine. 2005, Vol 23, Num 14, pp 1715-1719, issn 0264-410X, 5 p.Article

International Symposium on Combination VaccinesBREIMAN, Robert; GOLDENTHAL, Karen.Clinical infectious diseases. 2001, Vol 33, issn 1058-4838, 123 p., SUP4Conference Proceedings

Le programme élargi de vaccination (PEV). Situation actuelle = The enlanged program of vaccinations (EPV). Actual stateDEMAY, G.Le Pédiatre. 1986, Vol 22, Num 99, pp 303-312, issn 0397-9180Article

KHIMICHESKIE ASSOTSIIROVANNYE VAKTSINY. = VACCINS CHIMIQUES ASSOCIES1975; MOSKVA; TIPOGR. VDNKH.; DA. 1975; PP. 1-221; BIBL. DISSEM.Book

Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in childrenHANQING HE; ENFU CHEN; HAIPING CHEN et al.Vaccine. 2014, Vol 32, Num 31, pp 4001-4005, issn 0264-410X, 5 p.Article

The Immunisation Beliefs and Intentions Measure (IBIM): Predicting parents' intentions to immunise preschool childrenTICKNER, Sarah; LEMAN, Patrick J; WOODCOCK, Alison et al.Vaccine. 2010, Vol 28, Num 19, pp 3350-3362, issn 0264-410X, 13 p.Article

Prevention of Meningococcal Disease: Current Use of Polysaccharide and Conjugate VaccinesPOLAND, Gregory A.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S45-S53, SUP2Article

Group B streptococcal conjugate vaccinesBAKER, C. J; EDWARDS, M. S.Archives of disease in childhood. 2003, Vol 88, Num 5, pp 375-378, issn 0003-9888, 4 p.Article

Manufacturing issues related to combining different antigens: An industry perspectiveVAN HOOF, J.Clinical infectious diseases. 2001, Vol 33, pp S346-S350, issn 1058-4838, SUP4Conference Paper

Vaccine nomenclature : the three-letter codeMAURER, W.Vaccine. 2000, Vol 18, Num 15, pp 1539-1542, issn 0264-410XArticle

Combined conjugate vaccines : Enhanced immunogenicity with the N19 polyepitope as a carrier proteinBARALDO, Karin; MORI, Elena; BARTOLONI, Antonella et al.Infection and immunity. 2005, Vol 73, Num 9, pp 5835-5841, issn 0019-9567, 7 p.Article

Bacterial polysaccharide-protein conjugate vaccinesFINN, Adam.British medical bulletin. 2004, Vol 70, pp 1-14, issn 0007-1420, 14 p.Article

Impact of the meningococcal C conjugate vaccine in Spain: An epidemiological and microbiological decisionCANO, R; LARRAURI, A; MATEO, S et al.Euro surveillance. 2004, Vol 9, Num 3, pp 11-15, issn 1025-496X, 5 p.Article

Effect of needle change and air bubble in syringe on minor adverse reactions associated with diphtheria-tetanus toxoids-pertussis-polio vaccination in infantsIPP, M; GOLDBACH, M; GREENBERG, S et al.The Pediatric infectious disease journal. 1990, Vol 9, Num 4, pp 291-293, issn 0891-3668Conference Paper

Etude de l'efficacité du vaccin vivant combiné oreillons-rougeoleUNANOV, S. S; KORZH, YU. N; DOROFEEV, V. M et al.Voprosy virusologii. 1987, Vol 32, Num 6, pp 715-718, issn 0507-4088Article

An assessment of the safety of adolescent and adult tetanus―diphtheria―acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety DatalinkKATHERINE YIH, W; NORDIN, James D; KULLDORFF, Martin et al.Vaccine. 2009, Vol 27, Num 32, pp 4257-4262, issn 0264-410X, 6 p.Article

Persistence of Rubella Antibodies after 2 Doses of Measles-Mumps-Rubella VaccineLEBARON, Charles W; FORGHANI, Bagher; MATTER, Lukas et al.The Journal of infectious diseases. 2009, Vol 200, Num 6, pp 888-899, issn 0022-1899, 12 p.Article

Combination vaccines: Defining and addressing current safety concernsHALSEY, Neal A.Clinical infectious diseases. 2001, Vol 33, pp S312-S318, issn 1058-4838, SUP4Conference Paper

Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccinesWAIGHT, P. A; POLLOCK, T. M; MILLER, E et al.Archives of disease in childhood. 1983, Vol 58, Num 11, pp 921-923, issn 0003-9888Article

Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccinesESKOLA, J.Journal of internal medicine. 2010, Vol 267, Num 3, pp 241-250, issn 0954-6820, 10 p.Article

The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreakTALBOT, Elizabeth A; BROWN, Kristin H; KIRKLAND, Kathryn B et al.Vaccine. 2010, Vol 28, Num 50, pp 8001-8007, issn 0264-410X, 7 p.Article